4.7 Review

Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota

Journal

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fcimb.2022.851140

Keywords

probiotics; bacteriocins; dysbiosis; gut microbiota; modulation; immunity

Funding

  1. Department of Biotechnology [BT/PR8911/NDB/39/423/2013]
  2. Indian Council of Medical Research [5/9/1117/2013-NUT]

Ask authors/readers for more resources

Lactic acid bacteria can cure diseases and modulate gut microbiota by producing bacteriocins, making them effective in treating various human disorders.
Several strains of lactic acid bacteria are potent probiotics and can cure a variety of diseases using different modes of actions. These bacteria produce antimicrobial peptides, bacteriocins, which inhibit or kill generally closely related bacterial strains and other pathogenic bacteria such as Listeria, Clostridium, and Salmonella. Bacteriocins are cationic peptides that kill the target cells by pore formation and the dissipation of cytosolic contents, leading to cell death. Bacteriocins are also known to modulate native microbiota and host immunity, affecting several health-promoting functions of the host. In this review, we have discussed the ability of bacteriocin-producing probiotic lactic acid bacteria in the modulation of gut microbiota correcting dysbiosis and treatment/maintenance of a few important human disorders such as chronic infections, inflammatory bowel diseases, obesity, and cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available